Vidipha Central Pharmaceutical JSC (HOSE:VDP)

Market Cap	1.30T +70.5%
Revenue (ttm)	985.64B +5.5%
Net Income	63.81B -11.2%
EPS	2,889.38 -11.2%
Shares Out	22.08M
PE Ratio	20.42
Forward PE	n/a
Dividend	2,500.00 (4.24%)
Ex-Dividend Date	n/a

Volume	250
Average Volume	2,636
Open	60,500
Previous Close	60,500
Day's Range	60,500 - 60,500
52-Week Range	33,800 - 60,500
Beta	-0.08
RSI	65.40
Earnings Date	Apr 15, 2026

About HOSE:VDP

Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products under the Vidipha brand. It offers analgesics, antipyretics, gastrointestinal agents, antidiabetic agents, antibiotics, antivirals, antifungals, antihistamines, anti-allergic agents, respiratory agents, cardiovascular, neurological, antihypertensive agents, diuretics, vitamin, minerals, antiseptics, and others. The company also engages in hotel and real estate business; and provision of drug storage and testing, and technology transfer consulting servi...

• Industry: Pharmaceutical Preparations
• Founded: 2003
• Employees: 195
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: VDP

Financial Performance

In 2025, HOSE:VDP's revenue was 985.64 billion, an increase of 5.47% compared to the previous year's 934.49 billion. Earnings were 63.81 billion, a decrease of -11.16%.